Doral

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Narcolepsy2 trials
• Depression1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Axsome Therapeutics, Inc.3 trials

Running trials

• Recruiting

  A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

  NCT06223880· Phase 4· Axsome Therapeutics, Inc.· Source

  Contact: Study Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Depression1 recruiting

Closed trials

• Completed

  A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE)

  NCT05113745· Phase 3· Axsome Therapeutics, Inc.· Source

• Completed

  A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy

  NCT05059223· Phase 3· Axsome Therapeutics, Inc.· Source